{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:52Z","timestamp":1791216532493,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Nanjing Pharmaceutical Association-Changzhou Siyao Hospital Pharmaceutical Research Fund","award":["2022YX013"],"award-info":[{"award-number":["2022YX013"]}]},{"name":"Hospital Pharmacy Foundation of Jiangsu Pharmaceutical Association-Chia Tai Tianqing Pharmaceutical Industry Limited Company","award":["Q202220"],"award-info":[{"award-number":["Q202220"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04332-6","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T01:31:17Z","timestamp":1750642277000},"page":"686-697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Height benefits after GnRHa treatment in girls aged over 6 years with central precocious puberty: a meta-analysis"],"prefix":"10.1007","volume":"89","author":[{"given":"Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-ming","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"3","key":"4332_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","volume":"4","author":"AC Latronico","year":"2016","unstructured":"A.C. Latronico, V.N. Brito, J.C. Carel, Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 4(3), 265\u2013274 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"4332_CR2","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/EJE-15-0590","volume":"174","author":"F Guaraldi","year":"2016","unstructured":"F. Guaraldi, G. Beccuti, D. Gori, L. Ghizzoni, Management of endocrine disease: long-term outcomes of the treatment of central precocious puberty. Eur. J. Endocrinol. 174(3), R79\u2013R87 (2016).","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"4332_CR3","first-page":"345","volume":"90","author":"V De Sanctis","year":"2019","unstructured":"V. De Sanctis, A.T. Soliman, S. Di Maio, N. Soliman, H. Elsedfy, Long-term effects and significant adverse drug reactions (Adrs) associated with the use of gonadotropin-releasing hormone analogs (Gnrha) for central precocious puberty: a brief review of literature. Acta Bio-Medica: Atenei Parmensis 90(3), 345\u2013359 (2019).","journal-title":"Acta Bio-Medica: Atenei Parmensis"},{"issue":"Suppl 2","key":"4332_CR4","first-page":"33","volume":"9","author":"A Bereket","year":"2017","unstructured":"A. Bereket, A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty. J. Clin. Res. Pediatr. Endocrinol. 9(Suppl 2), 33\u201348 (2017).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"3","key":"4332_CR5","doi-asserted-by":"publisher","first-page":"dgz027","DOI":"10.1210\/clinem\/dgz027","volume":"105","author":"J Fu","year":"2020","unstructured":"J. Fu, J. Zhang, R. Chen, X. Ma, C. Wang, L. Chen et al., Long-term outcomes of treatments for central precocious puberty or early and fast puberty in chinese girls. J. Clin. Endocrinol. Metab. 105(3), dgz027 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4332_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000501336","volume":"91","author":"K Bangalore Krishna","year":"2019","unstructured":"K. Bangalore Krishna, J.S. Fuqua, A.D. Rogol, K.O. Klein, J. Popovic, C.P. Houk et al., Use of gonadotropin-releasing hormone analogs in children: update by an international consortium. Hormone Res. Paediatr. 91(6), 357\u2013372 (2019).","journal-title":"Hormone Res. Paediatr."},{"issue":"2","key":"4332_CR7","first-page":"331","volume":"79","author":"GB Kletter","year":"1994","unstructured":"G.B. Kletter, R.P. Kelch, Clinical review 60: effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J. Clin. Endocrinol. Metab. 79(2), 331\u2013334 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"4332_CR8","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","volume":"86","author":"KO Klein","year":"2001","unstructured":"K.O. Klein, K.M. Barnes, J.V. Jones, P.P. Feuillan, G.B. Cutler Jr., Increased final height in precocious puberty after long-term treatment with Lhrh agonists: the national institutes of health experience. J. Clin. Endocrinol. Metab. 86(10), 4711\u20134716 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4 Pt 1","key":"4332_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1542\/peds.104.4.936","volume":"104","author":"PB Kaplowitz","year":"1999","unstructured":"P.B. Kaplowitz, S.E. Oberfield, Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. drug and therapeutics and executive committees of the lawson wilkins pediatric endocrine society. Pediatrics 104(4 Pt 1), 936\u2013941 (1999).","journal-title":"Pediatrics"},{"issue":"27","key":"4332_CR10","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1097\/MD.0000000000000260","volume":"93","author":"P Li","year":"2014","unstructured":"P. Li, Y. Li, C.L. Yang, Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis. Medicine 93(27), e260 (2014).","journal-title":"Medicine"},{"issue":"6","key":"4332_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00431-017-2898-8","volume":"176","author":"S Bertelloni","year":"2017","unstructured":"S. Bertelloni, F. Massart, M. Miccoli, G.I. Baroncelli, Adult height after spontaneous pubertal growth or gnrh analog treatment in girls with early puberty: a meta-analysis. Eur. J. Pediatr. 176(6), 697\u2013704 (2017).","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"4332_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1530\/EJE-18-0473","volume":"179","author":"IA Franzini","year":"2018","unstructured":"I.A. Franzini, F.M. Yamamoto, F. Bolfi, S.R. Antonini, V.S. Nunes-Nogueira, Gnrh analog is ineffective in increasing adult height in girls with puberty onset after 7 years of age: a systematic review and meta-analysis. Eur. J. Endocrinol. 179(6), 381\u2013390 (2018).","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"4332_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"A. Stang, Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603\u2013605 (2010).","journal-title":"Eur. J. Epidemiol."},{"issue":"Suppl","key":"4332_CR14","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.12701\/jyms.2023.00801","volume":"40","author":"HJ Jang","year":"2023","unstructured":"H.J. Jang, M.J. Kwak, Y.M. Kim, S.H. Choi, K.H. Park, H.W. Yoo et al., Adult height in girls with central precocious puberty without gonadotropin-releasing hormone agonist treatment: a retrospective case-control study. J. Yeungnam Med. Sci. 40(Suppl), S81\u2013S86 (2023).","journal-title":"J. Yeungnam Med. Sci."},{"issue":"11","key":"4332_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.15537\/smj.2017.11.21187","volume":"38","author":"HH Swaiss","year":"2017","unstructured":"H.H. Swaiss, N.M. Khawaja, O.H. Farahid, A.M. Batieha, K.M. Ajlouni, Effect of gonadotropin-releasing hormone analogue on final adult height among jordanian children with precocious puberty. Saudi Med. J. 38(11), 1101\u20131107 (2017).","journal-title":"Saudi Med. J."},{"issue":"8","key":"4332_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3109\/09513590.2010.507289","volume":"27","author":"P Poomthavorn","year":"2011","unstructured":"P. Poomthavorn, R. Suphasit, P. Mahachoklertwattana, Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol. Endocrinol. 27(8), 524\u2013528 (2011).","journal-title":"Gynecol. Endocrinol."},{"issue":"1","key":"4332_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1210\/jc.2007-1216","volume":"93","author":"AM Pasquino","year":"2008","unstructured":"A.M. Pasquino, I. Pucarelli, F. Accardo, V. Demiraj, M. Segni, R. Di Nardo, Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. J. Clin. Endocrinol. Metab. 93(1), 190\u2013195 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4332_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1008474","volume":"13","author":"T Knific","year":"2022","unstructured":"T. Knific, M. Lazarevic, J. Zibert, N. Obolnar, N. Aleksovska, J. Suput Omladic et al., Final adult height in children with central precocious puberty - a retrospective study. Front. Endocrinol. 13, 1008474 (2022).","journal-title":"Front. Endocrinol."},{"key":"4332_CR19","doi-asserted-by":"crossref","unstructured":"R. Saito, K. Ozaki, Y. Baba, K. Ikegawa, K. Nagasaki, A. Nakamura, et al. Adult height in girls with central precocious puberty with onset after 6 years: effects of gonadotropin-releasing hormone analog therapy. Horm. Res. Paediatr., 1\u20138 (2024)","DOI":"10.1159\/000542038"},{"issue":"2","key":"4332_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.14740\/jocmr3710","volume":"11","author":"O Korkmaz","year":"2019","unstructured":"O. Korkmaz, G. Sari, I. Mecidov, S. Ozen, D. Goksen, S. Darcan, The gonadotropin-releasing hormone analogue therapy may not impact final height in precocious puberty of girls with onset of puberty aged 6\u20138 years. J. Clin. Med. Res. 11(2), 133\u2013136 (2019).","journal-title":"J. Clin. Med. Res."},{"key":"4332_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1515\/JPEM.2000.13.S1.773","volume":"13","author":"F Antoniazzi","year":"2000","unstructured":"F. Antoniazzi, T. Arrigo, M. Cisternino, F. Galluzzi, S. Bertelloni, A.M. Pasquino et al., End results in central precocious puberty with gnrh analog treatment: the data of the italian study group for physiopathology of puberty. J. Pediatr. Endocrinol. Metab. 13, 773\u2013780 (2000).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"4332_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000456546","volume":"87","author":"MF Faienza","year":"2017","unstructured":"M.F. Faienza, G. Brunetti, A. Acquafredda, M. Delvecchio, A. Lonero, A. Gaeta et al., Metabolic outcomes, bone health, and risk of polycystic ovary syndrome in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogues. Horm. Res. Paediatr. 87(3), 162\u2013169 (2017).","journal-title":"Horm. Res. Paediatr."},{"issue":"4","key":"4332_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1210\/jc.2014-3748","volume":"100","author":"L Lazar","year":"2015","unstructured":"L. Lazar, Y. Lebenthal, M. Yackobovitch-Gavan, S. Shalitin, L. de Vries, M. Phillip et al., Treated and untreated women with idiopathic precocious puberty: Bmi evolution, metabolic outcome, and general health between third and fifth decades. J. Clin. Endocrinol. Metab. 100(4), 1445\u20131451 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4332_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000184152","volume":"42","author":"B Stasiowska","year":"1994","unstructured":"B. Stasiowska, S. Vannelli, L. Benso, Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotrophin-releasing hormone (Buserelin). Hormone Res. 42(3), 81\u201385 (1994).","journal-title":"Hormone Res."},{"issue":"1","key":"4332_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-09-1102","volume":"163","author":"V Chiavaroli","year":"2010","unstructured":"V. Chiavaroli, M. Liberati, F. D\u2019Antonio, F. Masuccio, R. Capanna, A. Verrotti et al. Gnrh analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome. Eur. J. Endocrinol. 163(1), 55\u201362 (2010).","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"4332_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4274\/jcrpe.2356","volume":"8","author":"S Savas-Erdeve","year":"2016","unstructured":"S. Savas-Erdeve, Z. Siklar, B. Hacihamdioglu, P. Kocaay, E. Camtosun, G. Ocal et al. Gonadotropin-Releasing hormone analogue treatment in females with moderately early puberty: no effect on final height. J. Clin. Res. Pediatr. Endocrinol. 8(2), 211\u2013217 (2016).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"2","key":"4332_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000185432","volume":"47","author":"R Kauli","year":"1997","unstructured":"R. Kauli, A. Galatzer, L. Kornreich, L. Lazar, A. Pertzelan, Z. Laron, Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or gnrh analogue. a comparative study with re-evaluation of predictions by the bayley-pinneau method. Horm. Res. 47(2), 54\u201361 (1997).","journal-title":"Horm. Res."},{"key":"4332_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/abr.abr_121_19","volume":"8","author":"G Hajzadeh","year":"2019","unstructured":"G. Hajzadeh, N. Ghaemi, M.A. Hadjzadeh, S. Noroozi, N. Morovatdar, The effects of gonadotropin-releasing hormone analog and a combination of gonadotropin-releasing hormone analog and recombinant human growth hormone on adult height in girls with early puberty. Adv. Biomed. Res. 8, 57 (2019).","journal-title":"Adv. Biomed. Res."},{"issue":"1","key":"4332_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/pst.2068","volume":"20","author":"C Luchini","year":"2021","unstructured":"C. Luchini, N. Veronese, A. Nottegar, J.I. Shin, G. Gentile, U. Granziol et al. Assessing the quality of studies in meta-research: review\/guidelines on the most important quality assessment tools. Pharm. Stat. 20(1), 185\u2013195 (2021).","journal-title":"Pharm. Stat."},{"key":"4332_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK Lo","year":"2014","unstructured":"C.K. Lo, D. Mertz, M. Loeb, Newcastle-Ottawa scale: comparing Reviewers\u2019 to authors\u2019 assessments. BMC Med. Res. Methodol. 14, 45 (2014).","journal-title":"BMC Med. Res. Methodol."},{"issue":"8","key":"4332_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/ACM.0000000000000786","volume":"90","author":"DA Cook","year":"2015","unstructured":"D.A. Cook, D.A. Reed, Appraising the quality of medical education research methods: the medical education research study quality instrument and the newcastle-ottawa scale-education. Acad. Med. 90(8), 1067\u20131076 (2015).","journal-title":"Acad. Med."},{"issue":"9","key":"4332_CR32","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1210\/jc.2007-0321","volume":"92","author":"L Lazar","year":"2007","unstructured":"L. Lazar, A. Padoa, M. Phillip, Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J. Clin. Endocrinol. Metab. 92(9), 3483\u20133489 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"4332_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jpeds.2013.05.033","volume":"163","author":"KA Lewis","year":"2013","unstructured":"K.A. Lewis, A.K. Goldyn, K.W. West, E.A. Eugster, A single histrelin implant is effective for 2 years for treatment of central precocious puberty. J. Pediatr. 163(4), 1214\u20131216 (2013).","journal-title":"J. Pediatr."},{"issue":"10","key":"4332_CR34","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1210\/jcem.84.10.6032","volume":"84","author":"C Bouvattier","year":"1999","unstructured":"C. Bouvattier, J. Coste, D. Rodrigue, C. Teinturier, J.C. Carel, J.L. Chaussain et al. Lack of effect of Gnrh agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J. Clin. Endocrinol. Metab. 84(10), 3575\u20133578 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4332_CR35","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"D. Luo, X. Wan, J. Liu, T. Tong, Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat. Methods Med. Res. 27(6), 1785\u20131805 (2018).","journal-title":"Stat. Methods Med. Res."},{"key":"4332_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"X. Wan, W. Wang, J. Liu, T. Tong, Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol. 14, 135 (2014).","journal-title":"BMC Med. Res. Methodol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04332-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04332-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04332-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T21:36:22Z","timestamp":1757194582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04332-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04332-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}